Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominately
affects women. It is characterised by a broad spectrum of clinical manifestations, however, its …

This review describes the complex interplay between inflammation, vasculopathy and
fibrosis that involve the heart and peripheral small vessels, leading to endothelial stiffness …

Introduction The systemic inflammatory nature of systemic lupus erythematosus (SLE) is well
patent not only in the diverse clinical manifestations of the disease but also in the increased …

Despite improvements in patient and renal death rates following the introduction of potent
immunosuppressive drugs in earlier decades, a sizeable fraction of patients with lupus …

Recent discoveries have placed increased emphasis on the immunology of atherosclerotic
cardiovascular disease. Understanding the factors that drive the increased risk for …

Flow-mediated dilation (FMD) represents a non-invasive marker of endothelial function to
evaluate vascular homeostasis, which reflects the effects of several mechanisms, including …

Background: Systemic Lupus Erythematosus (SLE) is characterised by increased mortality
secondary to Cardiovascular Diseases (CVD). Despite being common in SLE, traditional …

Objective Patients with systemic lupus erythematosus (SLE) have a high burden of
cardiovascular disease (CVD) of multifactorial origin. The aim of this systematic review is to …

Background: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune
disease and patients are under an increased risk for cardiovascular (CV) events and …